HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Moriya Iwaizumi Selected Research

Adenocarcinoma

9/2020DNA mismatch repair is not disrupted in stage 0 colorectal cancer resected using endoscopic submucosal dissection.
1/2018Prevalence of elevated microsatellite alterations at selected tetranucleotide repeats in pancreatic ductal adenocarcinoma.
1/2014Guggulsterone, a plant-derived inhibitor of NF-TB, suppresses CDX2 and COX-2 expression and reduces the viability of esophageal adenocarcinoma cells.
2/2009[A case of elderly esophageal adenocarcinoma successfully treated with daily low-dose nedaplatin (CDGP) and continuous infusion of 5-FU combined with radiation].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Moriya Iwaizumi Research Topics

Disease

17Ulcerative Colitis
01/2024 - 12/2018
16Neoplasms (Cancer)
05/2024 - 11/2010
12Colorectal Neoplasms (Colorectal Cancer)
03/2024 - 11/2010
8Crohn Disease (Crohn's Disease)
04/2024 - 01/2017
5Stomach Neoplasms (Stomach Cancer)
08/2020 - 08/2009
4Adenocarcinoma
09/2020 - 02/2009
3Infections
05/2023 - 08/2014
3Esophageal Squamous Cell Carcinoma
11/2020 - 11/2009
3Esophageal Neoplasms (Esophageal Cancer)
11/2020 - 11/2009
2Adenoma (Adenomas)
03/2024 - 11/2022
2Rectal Neoplasms (Rectal Cancer)
03/2024 - 03/2023
2Gastroesophageal Reflux (GERD)
07/2021 - 01/2018
2Inflammation (Inflammations)
01/2021 - 12/2018
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2021 - 01/2017
2Turcot syndrome
02/2018 - 01/2016
2Lung Neoplasms (Lung Cancer)
09/2017 - 10/2013
1Brain Neoplasms (Brain Tumor)
05/2024
1Sarcoma (Soft Tissue Sarcoma)
05/2024
1Glioma (Gliomas)
05/2024
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
03/2024
1Carcinogenesis
01/2023
1Polyps
11/2022
1Pathologic Constriction (Stenosis)
01/2022
1Medullary Carcinoma
10/2021
1Carcinoma (Carcinomatosis)
10/2021
1Carcinoid Tumor (Carcinoid)
07/2021
1Bone Resorption
01/2021
1Asthma (Bronchial Asthma)
01/2021
1Neuroendocrine Carcinoma
12/2020
1Dizziness (Lightheadedness)
12/2020
1Tuberous Sclerosis (Bourneville's Disease)
12/2020
1Neuroendocrine Tumors (Neuroendocrine Tumor)
12/2020
1Chromosomal Instability (Chromosome Stability)
09/2020
1Disease Progression
07/2020
1Esophageal Stenosis (Esophageal Stricture)
05/2020
1Carcinoma in Situ
05/2020

Drug/Important Bio-Agent (IBA)

9Biomarkers (Surrogate Marker)IBA
12/2023 - 01/2018
9DNA (Deoxyribonucleic Acid)IBA
09/2023 - 08/2009
9Fluorouracil (Carac)FDA LinkGeneric
02/2018 - 02/2009
8Proteins (Proteins, Gene)FDA Link
09/2023 - 11/2010
6C-Reactive ProteinIBA
04/2024 - 12/2020
4AlbuminsIBA
04/2024 - 12/2020
4ProstaglandinsIBA
01/2022 - 04/2020
411 alpha- hydroxy- 9,15- dioxo- 2,3,4,5,20- pentanor- 19- carboxyprostanoic acidIBA
01/2022 - 04/2020
3SteroidsIBA
04/2024 - 06/2021
3Hemoglobins (Hemoglobin)IBA
04/2024 - 12/2020
3Leukocyte L1 Antigen Complex (Calgranulin)IBA
12/2023 - 01/2021
3Capsules (Microcapsules)IBA
01/2022 - 12/2018
3Serum AlbuminIBA
01/2022 - 01/2021
3nedaplatinIBA
11/2020 - 02/2009
3Calcibiotic Root Canal SealerIBA
08/2015 - 01/2012
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2024 - 01/2017
2Adalimumab (Humira)FDA Link
01/2024 - 01/2021
2Infliximab (Remicade)FDA Link
01/2024 - 07/2020
2Indicators and Reagents (Reagents)IBA
05/2023 - 01/2017
2Tacrolimus (Prograf)FDA LinkGeneric
01/2022 - 06/2021
2AcidsIBA
07/2021 - 01/2018
2Proton Pump InhibitorsIBA
07/2021 - 04/2017
2Messenger RNA (mRNA)IBA
01/2017 - 08/2009
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
05/2024
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
05/2024
1Sirolimus (Rapamycin)FDA Link
05/2024
1Phosphotransferases (Kinase)IBA
05/2024
1tyrosine receptor (receptor, tyrosine)IBA
05/2024
1Ustekinumab (CNTO 1275)FDA Link
04/2024
1golimumabFDA Link
01/2024
1AntibodiesIBA
01/2024
1Formaldehyde (Formol)FDA Link
09/2023
1ParaffinIBA
09/2023
1Nucleic AcidsIBA
05/2023
1peptidase NIBA
01/2023
1Syndecan-2IBA
01/2023
1theasinensin AIBA
11/2022
1tofacitinibIBA
01/2022
11- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA
07/2021
1benralizumabIBA
01/2021
1Collagen Type I (Type I Collagen)IBA
01/2021
1trans-sodium crocetinate (crocetin)IBA
12/2020
1Delayed-Action PreparationsIBA
12/2020
1TabletsIBA
12/2020
1Mesalamine (Mesalazine)FDA LinkGeneric
12/2020
1PlatinumIBA
11/2020
1MutS ProteinsIBA
09/2020
1MutL Protein Homolog 1IBA
09/2020
1Talaporfin (talaporfin sodium)IBA
05/2020
11-phenyl-3,3-dimethyltriazene (PDT)IBA
05/2020
1Anti-Infective Agents (Microbicides)IBA
01/2020
1Clarithromycin (Biaxin)FDA LinkGeneric
01/2020

Therapy/Procedure

10Therapeutics
01/2024 - 01/2015
5Drug Therapy (Chemotherapy)
02/2018 - 11/2009
4Colectomy
03/2023 - 10/2021
4Chemoradiotherapy
11/2020 - 02/2009
2Restorative Proctocolectomy
03/2024 - 03/2023
1Genomic Medicine
05/2024
1Precision Medicine
05/2024
1Remission Induction
06/2021
1Enterostomy
02/2021
1Salvage Therapy
05/2020
1Radiotherapy
05/2020
1Photochemotherapy (Photodynamic Therapy)
05/2020